Search for: "Purdue Pharma Company, The"
Results 1 - 20
of 306
Sort by Relevance
|
Sort by Date
19 Mar 2024, 3:30 am
Maureen Carroll By the end of this Term, SCOTUS must decide what to do about the mammoth Purdue Pharma bankruptcy settlement. [read post]
8 Mar 2024, 9:05 pm
Simon objects to the proliferation of bankruptcy “grifters,” whom she describes as solvent, non-debtor third parties that benefit from a company’s Chapter 11 filing—such as the Sackler family in the Purdue Pharma bankruptcy. [read post]
28 Feb 2024, 7:00 am
NEW YORK TO GET OVER $19 MILLIONIn early February, New York State Attorney General Letitia James announced a settlement with Publicis Health, LLC – the world’s largest healthcare advertising agency – resolving allegations relating to that company’s involvement in promoting the sales of opioids, like Oxycontin.Among other things, it is alleged that the company developed physician-directed marketing campaigns which falsely described such medications as safe… [read post]
22 Feb 2024, 2:14 pm
And however the Supreme Court rules in the Purdue Pharma case, the group observed, the U.S. [read post]
1 Jan 2024, 9:05 pm
Purdue Pharma L.P. [read post]
20 Dec 2023, 2:58 pm
Similarly, the Sackler family chose White Plains as the venue to file the bankruptcy of opioid producer Purdue Pharma (with nothing more than leased office space as a connection) because it was thought to be a forum that would allow them to bind dissenting tort claimants to releases of non-debtor members of the Sackler family. [read post]
12 Dec 2023, 5:22 am
Purdue Pharma pled guilty to three criminal charges by 2020. [read post]
7 Dec 2023, 12:11 pm
The Purdue Pharma bankruptcy case will significantly impact workers’ compensation cases nationally. [read post]
5 Dec 2023, 7:20 am
Much of yesterday's oral argument in the Purdue Pharma case focused on a predictive question. [read post]
4 Dec 2023, 1:42 pm
Purdue Pharma – but not the Sacklers – filed for bankruptcy in 2019, and a bankruptcy court in New York put lawsuits against both the company and the Sackler family on hold shortly after that. [read post]
4 Dec 2023, 6:51 am
The Supreme Court on Monday is hearing arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids. [read post]
3 Dec 2023, 10:38 am
“At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements? [read post]
3 Dec 2023, 5:29 am
The question on which the court granted review in Purdue Pharma’s case looks deceptively narrower: whether, as part of the bankruptcy deal for Purdue, the manufacturer of OxyContin, the owners of the company, the Sackler family, could be shielded from all civil liability in exchange for a $6 billion contribution to the settlement. [read post]
2 Dec 2023, 10:40 am
Purdue Pharma, a challenge to the approval by the U.S. [read post]
22 Nov 2023, 10:58 am
Purdue Pharma, a challenge to the approval by the U.S. [read post]
21 Nov 2023, 10:00 am
In two weeks, the Supreme Court will be reviewing the aspect of the Purdue Pharma bankruptcy deal that lets the Sackler family off the litigation hook. [read post]
31 Oct 2023, 9:05 pm
The Purdue Pharma case does not stand alone. [read post]
12 Oct 2023, 6:29 pm
The post Purdue Pharma, tax cases headline December argument session appeared first on SCOTUSblog. [read post]
22 Sep 2023, 4:00 am
Revolving Door Redux: The DEA’s recently departed No. 2 returns to a Big Pharma consulting firm MSN – Joshua Goodman and Jim Mustian (Associated Press) | Published: 9/20/2023 The Drug Enforcement Administration’s (DEA) recently departed second-in-command returned for a new stint with the consulting firm where he previously advised Purdue Pharma and a drug distributor fighting sanctions over suspicious painkiller shipments. [read post]
14 Sep 2023, 12:46 pm
” Prelogar told the justices that she plans to file a petition for review by Oct. 13, but she suggested that the court could also treat Thursday’s emergency appeal as a petition for review, as it did recently in the case of the Purdue Pharma bankruptcy. [read post]
